APA
Thorarensen A., Dowty M. E., Banker M. E., Juba B., Jussif J., Lin T., Vincent F., Czerwinski R. M., Casimiro-Garcia A., Unwalla R., Trujillo J. I., Liang S., Balbo P., Che Y., Gilbert A. M., Brown M. F., Hayward M., Montgomery J., Leung L., Yang X., Soucy S., Hegen M., Coe J., Langille J., Vajdos F., Chrencik J. & Telliez J. (20170807). Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans. : Journal of medicinal chemistry.
Chicago
Thorarensen Atli, Dowty Martin E, Banker Mary Ellen, Juba Brian, Jussif Jason, Lin Tsung, Vincent Fabien, Czerwinski Robert M, Casimiro-Garcia Agustin, Unwalla Ray, Trujillo John I, Liang Sidney, Balbo Paul, Che Ye, Gilbert Adam M, Brown Matthew F, Hayward Matthew, Montgomery Justin, Leung Louis, Yang Xin, Soucy Sarah, Hegen Martin, Coe Jotham, Langille Jonathan, Vajdos Felix, Chrencik Jill and Telliez Jean-Baptiste. 20170807. Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans. : Journal of medicinal chemistry.
Harvard
Thorarensen A., Dowty M. E., Banker M. E., Juba B., Jussif J., Lin T., Vincent F., Czerwinski R. M., Casimiro-Garcia A., Unwalla R., Trujillo J. I., Liang S., Balbo P., Che Y., Gilbert A. M., Brown M. F., Hayward M., Montgomery J., Leung L., Yang X., Soucy S., Hegen M., Coe J., Langille J., Vajdos F., Chrencik J. and Telliez J. (20170807). Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans. : Journal of medicinal chemistry.
MLA
Thorarensen Atli, Dowty Martin E, Banker Mary Ellen, Juba Brian, Jussif Jason, Lin Tsung, Vincent Fabien, Czerwinski Robert M, Casimiro-Garcia Agustin, Unwalla Ray, Trujillo John I, Liang Sidney, Balbo Paul, Che Ye, Gilbert Adam M, Brown Matthew F, Hayward Matthew, Montgomery Justin, Leung Louis, Yang Xin, Soucy Sarah, Hegen Martin, Coe Jotham, Langille Jonathan, Vajdos Felix, Chrencik Jill and Telliez Jean-Baptiste. Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans. : Journal of medicinal chemistry. 20170807.